{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:47:21Z","timestamp":1774655241689,"version":"3.50.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS069614, NS89750, NS089750-01A1"],"award-info":[{"award-number":["NS069614, NS89750, NS089750-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neuroanat."],"abstract":"<jats:p>Huntington\u2019s disease (HD) is a dominantly inherited, adult-onset neurodegenerative disease characterized by motor, psychiatric, and cognitive abnormalities. Neurodegeneration is prominently observed in the striatum where GABAergic medium spiny neurons (MSN) are the most affected neuronal population. Interestingly, recent reports of pathological changes in HD patient striatal tissue have identified a significant reduction in the number of parvalbumin-expressing interneurons which becomes more robust in tissues of higher disease grade. Analysis of other interneuron populations, including somatostatin, calretinin, and cholinergic, did not reveal significant neurodegeneration. Electrophysiological experiments in BACHD mice have identified significant changes in the properties of parvalbumin and somatostatin expressing interneurons in the striatum. Furthermore, their interactions with MSNs are altered as the mHTT expressing mouse models age with increased input onto MSNs from striatal somatostatin and parvalbumin-expressing neurons. In order to determine whether BACHD mice recapitulate the alterations in striatal interneuron number as observed in HD patients, we analyzed the number of striatal parvalbumin, somatostatin, calretinin, and choline acetyltransferase positive cells in symptomatic 12\u201314 month-old mice by immunofluorescent labeling. We observed a significant decrease in the number of parvalbumin-expressing interneurons as well as a decrease in the area and perimeter of these cells. No significant changes were observed for somatostatin, calretinin, or cholinergic interneuron numbers while a significant decrease was observed for the area of cholinergic interneurons. Thus, the BACHD mice recapitulate the degenerative phenotype observed in the parvalbumin interneurons in HD patient striata without affecting the number of other interneuron populations in the striatum.<\/jats:p>","DOI":"10.3389\/fnana.2021.673177","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T04:23:28Z","timestamp":1621830208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["BACHD Mice Recapitulate the Striatal Parvalbuminergic Interneuron Loss Found in Huntington\u2019s Disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Vyshnavi","family":"Rallapalle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annesha C.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease","volume":"31","author":"Andre","year":"","journal-title":"J. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnsys.2011.00046","article-title":"Altered balance of activity in the striatal direct and indirect pathways in mouse models of Huntington\u2019s disease","volume":"5","author":"Andre","year":"","journal-title":"Front. Syst. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/1531-8257(199905)14:3<398::aid-mds1003>3.0.co;2-f","article-title":"Pathophysiology of chorea and bradykinesia in Huntington\u2019s disease","volume":"14","author":"Berardelli","year":"1999","journal-title":"Mov. Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1038\/s41598-018-30958-w","article-title":"Visual processing by calretinin expressing inhibitory neurons in mouse primary visual cortex","volume":"8","author":"Camillo","year":"2018","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington\u2019s disease mouse models","volume":"33","author":"Cepeda","year":"2013","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1073858420972662","article-title":"Synaptic dysfunction in Huntington\u2019s disease: lessons from genetic animal models","author":"Cepeda","year":"2020","journal-title":"Neuroscientist"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/brain\/111.5.1211","article-title":"Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea","volume":"111","author":"Crossman","year":"1988","journal-title":"Brain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.410270217","article-title":"Degeneration of pyramidal projection neurons in Huntington\u2019s disease cortex","volume":"27","author":"Cudkowicz","year":"1990","journal-title":"Ann. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11846","article-title":"Concurrent activation of striatal direct and indirect pathways during action initiation","volume":"494","author":"Cui","year":"2013","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnmol.2013.00042","article-title":"Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington\u2019s disease","volume":"6","author":"Czeredys","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1002\/cne.24013","article-title":"Cholinergic interneurons in the Q140 knockin mouse model of Huntington\u2019s disease: reductions in dendritic branching and thalamostriatal input","volume":"524","author":"Deng","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/cne.25023","article-title":"Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington\u2019s disease mice","volume":"529","author":"Deng","year":"2021","journal-title":"J. Comp. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1172\/JCI45646","article-title":"Brain networks in Huntington disease","volume":"121","author":"Eidelberg","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-8993(96)00801-3","article-title":"Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats","volume":"735","author":"Figueredo-Cardenas","year":"1996","journal-title":"Brain Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"18531","DOI":"10.1523\/JNEUROSCI.1278-13.2013","article-title":"Control of basal ganglia output by direct and indirect pathway projection neurons","volume":"33","author":"Freeze","year":"2013","journal-title":"J. Neurosci."},{"key":"B16","first-page":"3","article-title":"Chapter 1\u2014the neuroanatomical organization of the basal ganglia","volume-title":"Handbook of Behavioral Neuroscience","author":"Gerfen","year":"2016"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.1523\/JNEUROSCI.20-18-07052.2000","article-title":"Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia","volume":"20","author":"Gernert","year":"2000","journal-title":"J. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1460-9568.2009.06649.x","article-title":"Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6\/2 mouse model of Huntington\u2019s disease","volume":"29","author":"Giampa","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.tins.2012.06.008","article-title":"Striatal microcircuitry and movement disorders","volume":"35","author":"Gittis","year":"2012","journal-title":"Trends Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"15727","DOI":"10.1523\/JNEUROSCI.3875-11.2011","article-title":"Selective inhibition of striatal fast-spiking interneurons causes dyskinesias","volume":"31","author":"Gittis","year":"2011","journal-title":"J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","article-title":"Differential vulnerability of neurons in Huntington\u2019s disease: the role of cell type-specific features","volume":"113","author":"Han","year":"2010","journal-title":"J. Neurochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e19155","DOI":"10.1371\/journal.pone.0019155","article-title":"Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum","volume":"6","author":"Higley","year":"2011","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ejn.14283","article-title":"Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington\u2019s disease","volume":"49","author":"Holley","year":"","journal-title":"Eur. J. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnsyn.2019.00014","article-title":"Major contribution of somatostatin-expressing interneurons and cannabinoid receptors to increased GABA synaptic activity in the striatum of Huntington\u2019s disease mice","volume":"11","author":"Holley","year":"","journal-title":"Front. Synaptic Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"ENEURO.0008-14.2015","DOI":"10.1523\/ENEURO.0008-14.2015","article-title":"Enhanced GABAergic inputs contribute to functional alterations of cholinergic interneurons in the R6\/2 mouse model of Huntington\u2019s disease","volume":"2","author":"Holley","year":"2015","journal-title":"eNeuro"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1255263","DOI":"10.1126\/science.1255263","article-title":"Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function","volume":"345","author":"Hu","year":"2014","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1523\/JNEUROSCI.5996-09.2010","article-title":"Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum","volume":"30","author":"Ibanez-Sandoval","year":"2010","journal-title":"J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"16757","DOI":"10.1523\/JNEUROSCI.2628-11.2011","article-title":"A novel functionally distinct subtype of striatal neuropeptide Y interneuron","volume":"31","author":"Ibanez-Sandoval","year":"2011","journal-title":"J. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0166-2236(95)98374-8","article-title":"Striatal interneurones: chemical, physiological and morphological characterization","volume":"18","author":"Kawaguchi","year":"1995","journal-title":"Trends Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"113358","DOI":"10.1016\/j.expneurol.2020.113358","article-title":"Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington\u2019s disease","volume":"330","author":"King","year":"2020","journal-title":"Exp. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e35657","DOI":"10.7554\/eLife.35657","article-title":"Differential inputs to striatal cholinergic and parvalbumin interneurons imply functional distinctions","volume":"7","author":"Klug","year":"2018","journal-title":"Elife"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1097\/00001756-199912160-00031","article-title":"Intranuclear inclusions in subtypes of striatal neurons in Huntington\u2019s disease transgenic mice","volume":"10","author":"Kosinski","year":"1999","journal-title":"Neuroreport"},{"key":"B35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/exnr.1997.6441","article-title":"Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons","volume":"144","author":"Kosinski","year":"1997","journal-title":"Exp. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neures.2008.08.007","article-title":"The fate of the large striatal interneurons expressing calretinin in Huntington\u2019s disease","volume":"62","author":"Massouh","year":"2008","journal-title":"Neurosci. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/cne.10295","article-title":"Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6\/2 transgenic mice","volume":"449","author":"Meade","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cercor\/bhu179","article-title":"Novel striatal GABAergic interneuron populations labeled in the 5HT3a(EGFP) mouse","volume":"26","author":"Munoz-Manchado","year":"2016","journal-title":"Cereb. Cortex"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1523\/JNEUROSCI.0901-14.2014","article-title":"Striatal cholinergic neurotransmission requires VGLUT3","volume":"34","author":"Nelson","year":"2014","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0006-8993(95)00124-9","article-title":"Calretinin-immunoreactive neurons in the human striatum","volume":"674","author":"Parent","year":"1995","journal-title":"Brain Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddy119","article-title":"A whole brain longitudinal study in the YAC128 mouse model of Huntington\u2019s disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes","volume":"27","author":"Petrella","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jchemneu.2014.06.002","article-title":"Distribution and morphological characteristics of striatal interneurons expressing calretinin in mice: a comparison with human and nonhuman primates","author":"Petryszyn","year":"2014","journal-title":"J. Chem. Neuroanat."},{"key":"B43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00702-017-1687-x","article-title":"The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions","volume":"125","author":"Petryszyn","year":"2018","journal-title":"J. Neural Transm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"B46","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/cns.12844","article-title":"Disrupted striatal neuron inputs and outputs in Huntington\u2019s disease","volume":"24","author":"Reiner","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","article-title":"Genetics and neuropathology of Huntington\u2019s disease","volume":"98","author":"Reiner","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/mds.25624","article-title":"Striatal parvalbuminergic neurons are lost in Huntington\u2019s disease: implications for dystonia","volume":"28","author":"Reiner","year":"2013","journal-title":"Mov. Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","article-title":"Cholinergic neuronal defect without cell loss in Huntington\u2019s disease","volume":"15","author":"Smith","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B50","first-page":"157","article-title":"Chapter 8 - GABAergic interneurons of the striatum","volume-title":"Handbook of Behavioral Neuroscience","author":"Tepper","year":"2016"},{"key":"B51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2018.00091","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons: update 2018","volume":"12","author":"Tepper","year":"2018","journal-title":"Front. Neuroanat."},{"key":"B52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnana.2018.00091","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons","volume":"4","author":"Tepper","year":"2010","journal-title":"Front. Neuroanat."},{"key":"B53","doi-asserted-by":"publisher","first-page":"R267","DOI":"10.1016\/j.cub.2016.02.036","article-title":"Direct and indirect dorsolateral striatum pathways reinforce different action strategies","volume":"26","author":"Vicente","year":"2016","journal-title":"Curr. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/hmg\/ddy363","article-title":"Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington\u2019s disease mouse model","volume":"28","author":"Wood","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1523\/JNEUROSCI.0195-15.2015","article-title":"Are striatal tyrosine hydroxylase interneurons dopaminergic?","volume":"35","author":"Xenias","year":"2015","journal-title":"J. Neurosci."}],"container-title":["Frontiers in Neuroanatomy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnana.2021.673177\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T04:23:32Z","timestamp":1621830212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnana.2021.673177\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":59,"alternative-id":["10.3389\/fnana.2021.673177"],"URL":"https:\/\/doi.org\/10.3389\/fnana.2021.673177","relation":{},"ISSN":["1662-5129"],"issn-type":[{"value":"1662-5129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"article-number":"673177"}}